Page 26 - 75_03

YANNICK GOUMON Y COLS. AN. R. ACAD. NAC. FARM.

26. Marker, C. L., Stoffel, M. & Wickman, K. (2004) Spinal G-protein-gated
K+ channels formed by GIRK1 and GIRK2 subunits modulate thermal
nociception and contribute to morphine analgesia. J. Neurosci. 24(11): 2806-
2812.

27. Vaughan, C. W., Bagley, E. E., Drew, G. M., Schuller, A., Pintar, J. E., Hack,
S. P., et al. (2003) Cellular actions of opioids on periaqueductal grey neurons
from C57B16/J mice and mutant mice lacking MOR-1. Br. J. Pharmacol.
139(2): 362-367.

28. Marker, C. L., Lujan, R., Loh, H. H. & Wickman, K. (2005) Spinal G-protein-
gated potassium channels contribute in a dose-dependent manner to the
analgesic effect of mu- and delta- but not kappa-opioids. J. Neurosci. 25(14):
3551-3559.

29. Nakatsuka, T., Fujita, T., Inoue, K. & Kumamoto, E. (2008) Activation of
GIRK channels in substantia gelatinosa neurones of the adult rat spinal cord:
a possible involvement of somatostatin. J. Physiol. 586(10): 2511-2522.

30. Cruz, H. G., Berton, F., Sollini, M., Blanchet, C., Pravetoni, M., Wickman,
K., et al. (2008) Absence and rescue of morphine withdrawal in GIRK/Kir3
knock-out mice. J. Neurosci. 28(15): 4069-4077.

31. Torrecilla, M., Quillinan, N., Williams, J. T. & Wickman, K. (2008) Pre- and
postsynaptic regulation of locus coeruleus neurons after chronic morphine
treatment: a study of GIRK-knockout mice. Eur. J. Neurosci. 28(3): 618-624.

32. Coller, J. K., Christrup, L. L. & Somogyi, A. A. (2008) Role of active
metabolites in the use of opioids. Eur. J. Clin. Pharmacol.

33. Ohno, S. & Nakajin, S. (2009) Determination of mRNA expression of human
UDP-glucuronosyltransferases and application for localization in various
human tissues by real-time reverse transcriptase-polymerase chain reaction.
Drug Metab. Dispos. 37(1): 32-40.

34. Radominska-Pandya, A., Little, J. M. & Czernik, P. J. (2001) Human UDP-
glucuronosyltransferase 2B7. Curr. Drug Metab. 2(3): 283-298.

35. Yamada, H., Ishii, K., Ishii, Y., Ieiri, I., Nishio, S., Morioka, T., et al. (2003)
Formation of highly analgesic morphine-6-glucuronide following physiologic
concentration of morphine in human brain. J. Toxicol. Sci. 28(5): 395-401.

36. Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A.,
Belanger, A., et al. (1997) The UDP glycosyltransferase gene superfamily:
recommended nomenclature update based on evolutionary divergence.
Pharmacogenetics. 7(4): 255-269.

37. Mackenzie, P. I., Walter Bock, K., Burchell, B., Guillemette, C., Ikushiro,
S., Iyanagi, T., et al. (2005) Nomenclature update for the mammalian UDP
glycosyltransferase (UGT) gene superfamily. Pharmacogenet. Genomics. 15
(10): 677-685.

38. Ohno, S., Kawana, K. & Nakajin, S. (2008) Contribution of UDP-glucuro-
nosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic
properties. Drug Metab. Dispos. 36(4): 688-694.

39. King, C. D., Rios, G. R., Assouline, J. A. & Tephly, T. R. (1999) Expression
of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain

412